FDA approves new anti-influenza drug Xofluza; worked better than oseltamivir
www.pulmccm.org
The U.S. Food and Drug Administration (FDA) approved baloxavir marboxil, an oral tablet to be marketed as Xofluza, for treatment of early acute uncomplicated influenza in adolescents and adults. FDA Commissioner Scott Gottlieb said in a news release,
FDA approves new anti-influenza drug Xofluza; worked better than oseltamivir
FDA approves new anti-influenza drug Xofluza…
FDA approves new anti-influenza drug Xofluza; worked better than oseltamivir
The U.S. Food and Drug Administration (FDA) approved baloxavir marboxil, an oral tablet to be marketed as Xofluza, for treatment of early acute uncomplicated influenza in adolescents and adults. FDA Commissioner Scott Gottlieb said in a news release,